You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV16 positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • London, United Kingdom
    East and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023

Malignant Tumors of Ill-defined Secondary and Unspecified Sites, Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal

Terminated
Has Results
  • Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 22, 2022

Cervical Cancer, Anal Cancer, Head Neck Cancers Trial in Zhengzhou (Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01

Recruiting
  • Cervical Cancer
  • +2 more
  • Fludarabine + Cyclophosphamide
  • +2 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Jun 22, 2022

HSIL of Cervix Trial in Heze (NWRD08)

Recruiting
  • HSIL of Cervix
  • NWRD08
  • Heze, Shandong, China
    Heze Municipal Hospital
Jun 6, 2023

Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 20, 2022

Solid Tumors Trial in Houston (ISA 101, Nivolumab)

Completed
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 17, 2021

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

Recruiting
  • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
  • +3 more
  • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Gynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma Trial in France, Spain, United

Recruiting
  • HPV-Related Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +16 more
Feb 14, 2022

Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III Trial

Recruiting
  • Human Papillomavirus Type 16
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Jul 2, 2021

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)

Recruiting
  • Human Papilloma Virus
  • +3 more
  • Chicago, Illinois
    University of Chicago
Aug 11, 2022

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)

Recruiting
  • HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
  • HB-201 IT
  • HB-201 IV
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022

Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • RPTR-168
  • Scottsdale, Arizona
  • +3 more
Dec 2, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Medical Chart Review
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Mar 15, 2022

Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

Recruiting
  • Cervix Cancer
  • +2 more
  • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
  • Randers, Central Denmark Region, Denmark
    Department of Pathology
Feb 3, 2023

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)

Recruiting
  • Cancer of the Head and Neck
  • +3 more
  • Cisplatin injection
  • Columbia, Missouri
    University of Missouri
Oct 31, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal HPV-Positive Squamous Cell Carcinoma

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Oropharyngeal HPV-Positive Squamous Cell Carcinoma
  • Radiation Therapy
  • Atlanta, Georgia
  • +1 more
Jun 7, 2022